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Altered mitochondrial activities play an important role 
in many different human disorders, including cancer 
and neurodegeneration. At the Freiburg Institute of 
Advanced Studies (FRIAS) Junior Researcher Confer-
ence “One Mitochondrion, Many Diseases - Biological 
and Molecular Perspectives” (University of Freiburg, 
Freiburg, Germany), junior and experienced researches 
discussed common and distinct mechanisms of mito-
chondrial contributions to various human disorders. 
 
INTRODUCTION 
Mitochondria (greek: μίτος & χονδρίον, mitos & chondrion, 
i.e., thread & granule) are the power houses of eukaryotic 
cells, and are pivotally involved in essential metabolic pro-
cesses, including iron/sulfur cluster and heme biosynthesis. 
Mitochondria are highly dynamic organelles that constantly 
fuse (resulting in thread-like structures) and divide (form-
ing granular structures). They move along the cytoskeleton, 
and surplus or severely damaged organelles are degraded. 
The degradation occurs via mitophagy, i.e., a selective form 
of autophagy, where a double-membrane completely en-
closes the organelles. The resulting mitochondria-
containing autophagsomes finally fuse with the lysosomes 
or vacuoles, where the degradation takes place with the 
help of lysosomal or vacuolar proteases. The internal struc-
ture of mitochondria highly varies depending on the de-
mands of the cells. Critical damage of mitochondria or al-
tered mitochondrion-associated processes are linked to 
many human disorders, including neurodegeneration, can-
cer, and aberrant inflammatory processes. On March 
9
th
/10
th
, when spring was approaching, 100 scientists from 
Freiburg (Germany), as well as from Europe, and from 
overseas attended the 2
nd
 International Symposium “One 
mitochondrion, many diseases”. Due to the generous sup-
port of the Freiburg Institute of Advanced Studies (FRIAS) 
of the University of Freiburg (Germany), the researchers 
presented their recent data on physiological and patho-
physiological processes involving mitochondria and their 
relevance for cellular homeostasis and cellular dysfunc-
tions underlying various human disorders. 
 
DEREGULATED MITOCHONDRIAL PROTEIN HOMEO-
STASIS AND ITS ROLE IN DISEASE 
Jörn Dengjel (University of Fribourg, Fribourg, Switzerland) 
gave the opening lecture to the symposium. He introduced 
how mitochondrial dysfunction is linked to various human 
disorders, including mitochondrial disorders and myopa-
thies, as well as complex disorders such as neurodegenera-
tive disorders. He focused his talk on mitochondrial home-
ostasis by mitophagy, which has been proposed to be criti-
cal especially for Parkinson’s disease. In his previous work 
dissecting mitophagy in baker’s yeast using a quantitative 
proteomic approach, he elucidated that distinct mitochon-
drial matrix proteins are sorted into mitochondrial entities 
which are then degraded via mitophagy [1-3]. These hith-
erto unknown sorting mechanisms prior to mitophagy de-
termine mitochondrial protein homeostasis, and potential-
ly could play important roles in modulating mitochondrial 
(dys)function in health and disease. 
Jan Riemer (University of Cologne, Cologne, Germany) 
talked about the oxidation of thiols in mitochondrial res-
piratory chain assembly and calcium signaling. He intro-
duced into the mechanisms of the oxidative folding ma-
chinery. He focused his talk on how this machinery can 
work in a reducing environment, and how a crucial disul-
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fide bond regulates Ca
2+
 signaling [4, 5]. 
The majority of mitochondrial proteins is synthesized as 
precursor proteins in the cytosol and then imported into 
mitochondria. In most cases, the precursor proteins com-
prise N-terminal presequences, which are cleaved after 
import by mitochondrial presequence proteases. Nora 
Vögtle (University of Freiburg, Freiburg, Germany) de-
scribed the physiological role of these mitochondrial 
presequence proteases and their impact on mitochondri-
on-modulated disorders [6, 7]. The activities of these pro-
teases are tightly regulated by feedback loops and patho-
logical proteins, such as the Alzheimer’s disease-associated 
peptide β-amyloid, which impairs turnover of presequence 
peptides with detrimental consequences [8]. 
Ralf Braun (University of Bayreuth, Bayreuth, Germany) 
demonstrated that accumulation of mutant Alzheimer’s 
disease-associated ubiquitin impairs the ubiquitin-
proteasome system (UPS), leads to the aberrant enrich-
ment of enzymes in mitochondria, which elicit mitochon-
drial dysfunction and cell death [9, 10]. Intriguingly, pro-
moting the mitochondrion-associated branch of the UPS 
reduced the cellular levels of these enzymes and protected 
mitochondria and cells from the detrimental effects of 
mutant ubiquitin. These data indicate a pivotal role of UPS 
(dys)function in controlling metabolic activities in mito-
chondria with a potential relevance for human diseases. 
Julia Ring (University of Graz, Graz, Austria) described a 
yeast model expressing the Alzheimer’s disease-associated 
hydrophobic peptide β-amyloid. She demonstrated that β-
amyloid localizes to mitochondria executing oxidative 
stress and cell death. She identified factors that modulate 
the aberrant accumulation of these detrimental peptides 
at the mitochondrial outer membrane. 
 
FUNCTIONAL ARCHITECTURE AND DYNAMICS OF 
MITOCHONDRIA 
The inner-mitochondrial structure is highly dynamic and 
adapts to the needs of the cell. The components and 
mechanisms shaping inner mitochondrial membranes are 
currently elucidated. Martin van der Laan (Saarland Uni-
versity, Homburg, Germany) identified the mitochondrial 
contact sites and cristae-organizing system (MICOS), which 
controls mitochondrial inner membrane morphology, and 
enables multifunctional organization of mitochondria [11]. 
He focused his talk on the role of Mic10, which is the main 
component of the MICOS backbone in baker’s yeast [12, 
13]. He presented a hypothetical model how Mic10 shapes 
the mitochondrial cristae. Ralf Zerbes (University of Frei-
burg, Freiburg, Germany) delineated the role of another 
MICOS component. He described that Mic60 and its inter-
acting partner Mib26 link respiratory chain assembly with 
cristae formation. He proposed that MICOS is needed to 
provide the right localization of distinct respiratory chain 
components and assembly intermediates, i.e., the mito-
chondrial ultrastructure determines mitochondrial function. 
Mature mRNA contain unconventional open reading 
frames (AltORFs) located in the untranslated regions or 
overlapping the reference ORFs (RefORFs) in non-canonical 
+2 and +3 reading frames [14]. Xavier Roucou (University 
of Sherbrooke, Sherbrooke, QC, Canada) identified Alt-
MID51 encoded by an AltORF in the mRNA encoding the 
RefORF of the mitochondrial dynamics protein of 51 kDa 
(MID51). AltMID51 homodimerized in mitochondrial foci. 
The ORFs encoding AltMID51 and MID51 are evolutionary 
tightly associated, and overexpression of both proteins 
triggered mitochondrial fragmentation. These and other 
data propose that AltMID51 and MID51 are both involved 
in mitochondrial fragmentation. 
Denis Gris (University of Sherbrooke, Sherbrooke, QC, 
Canada) analyzes the role of proteins involved in the innate 
immune response on the survival of neurons. He is working 
on NLRX1, the only mitochondrial member of the nucleo-
tide-binding domain leucine-rich repeat-containing protein 
(NLR) family. He proposed that NLRX1 could be a molecular 
switch controlling both neuronal survival and inflammatory 
signaling [15]. NLRX1 activities have important effects on 
the structure of both the mitochondrial network, and the 
inner-mitochondrial organization. NLRX1 promotes mito-
chondrial fission, leading to increased number of mito-
chondria with reduced numbers of cristae [15]. 
 
MITOCHONDRIAL RESPIRATION AND HUMAN 
DISORDERS 
Verónica Dumit (University of Freiburg, Freiburg, Germa-
ny) presented her data with emodin, an anthraquinone 
component of aloe, which selectively affects the prolifera-
tion of cancer cells compared to healthy counterparts. 
Emodin treatment leads to the downregulation of mito-
chondrial complex I subunits in cancer cells, and triggers 
mitochondrial fragmentation and ballooning. Emodin shifts 
isolated yeast mitochondria towards uncoupled respiration, 
affects the mitochondrial membrane potential, which then 
leads to impaired import of proteins into the mitochondrial 
matrix. Yeast cells adapted to fermentation are more vul-
nerable to emodin treatment than yeast cells with high 
respiratory capacity. This effect might be comparable to 
cancer cells, which prefer fermentation in contrast to con-
trol cells, which demonstrate higher levels of respiratory 
activities. In summary, emodin detrimentally affects cells 
with an inefficient mitochondrial respiratory chain, such as 
cancer cells. 
Ulrich Brandt (Radboud University Medical Center, 
Nijmegen, The Netherlands) presented his work on the 
structure, function and regulation of the mitochondrial 
respiratory chain complex I, whose dysfunction is connect-
ed to various mitochondrial and mitochondrion-modulated 
disorders [16]. Most notably, he succeeded to resolve the 
X-ray structure of mitochondrial complex I [17], which will 
help develop targets for pharmacological treatments to 
ameliorate disease-associated complex I deficiency and 
oxidative stress production. 
 
ROLE OF MITOPHAGY IN HUMAN DISORDERS 
Florian Steinberg (University of Freiburg, Freiburg, Germa-
ny) talked about endocytic Rab GTPases on mitochondrial 
degradation via mitophagy. Rab GTPases are involved in 
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the regulation of membrane trafficking, including vesicle 
movement, and membrane fusion. Here, Florian Steinberg 
presented data that specific Rab GTPases interact with the 
mitochondrial fission machinery thereby pivotally modulat-
ing mitophagy. 
Konstanze Winklhofer (Ruhr University Bochum, Bo-
chum, Germany) talked about ubiquitin signaling and mito-
chondrial integrity and their implications for Parkinson’s 
disease. She introduced into the pivotal role of mitochon-
drial damage for Parkinson’s disease. Mutations in genes 
encoding components of the mitophagy machinery, includ-
ing the E3 ubiquitin ligase Parkin and the protein kinase 
Pink1, are causative for familiar forms of the human disor-
der. She challenged the paradigm that the protective role 
of Pink and Parkin in Parkinson’s disease depends on its 
role in mitophagy [18, 19]. Instead, she demonstrated that 
Parkin requires the NFκB pathway to mediate stress pro-
tection, as well as the mitochondrial fusion factor OPA1. 
Thus, the functions unrelated to mitophagy of Pink1 and 
Parkin should be further considered in dissecting mecha-
nisms of Parkinson’s disease. 
Iron-sulfur cluster biogenesis strictly depends on mito-
chondrial activity. Many “iron-sulfur diseases” including 
Friedreich’s ataxia exist, which are caused by mutations in 
components of the iron-sulfur cluster assembly machinery. 
Janina Bergmann (University of Marburg, Marburg, Ger-
many) presented her work challenging the question of 
whether mitochondria from iron-sulfur disease patients are 
removed via Pink1/Parkin-dependent mitophagy. She 
showed that mitochondria are severely impaired upon 
deficiency in iron-sulfur cluster biogenesis showing a res-
piratory insufficiency. Surprisingly, the diseased organelles 
can maintain a membrane potential via the reverse action 
of the F1/FO ATP synthase using ATP synthesized by in-
creased glycolysis. Consequently, no Pink1/Parkin-
dependent mitophagy could be observed confirming that 
the latter process is strictly dependent on a mitochondrial 
membrane potential. 
 
MODELING THE INHERITANCE AND EVOLUTION OF 
MITOCHONDRIAL DNA 
Mutations in mitochondrial DNA (mtDNA) are causative for 
severe mitochondrial disorders. Iain Johnston (University 
of Birmingham, Birmingham, UK) described work combin-
ing mathematical theory and experiments to characterize 
the evolution of mtDNA within cells, and the inheritance 
and onset of mitochondrial diseases. He introduced the 
concept of heteroplasmy, i.e., the fact that one cell may 
comprise more than one mtDNA haplotype. He demon-
strated that the proliferation of one haplotype over anoth-
er has to be considered in gene therapies to address dis-
eases, and that this phenomenon increases with the genet-
ic distance between the haplotypes [20, 21]. Damaged 
mtDNA can be eliminated during mammalian development 
through a highly debated mechanism called the mtDNA 
bottleneck; Johnston produced a new, physically motivated, 
generalizable theoretical model for mtDNA populations 
during development, allowing the first statistical compari-
son of proposed bottleneck mechanisms [22]. 
 
ROLE OF MITOCHONDRIA IN WILSON DISEASE AND 
ALZHEIMER’S DISEASE 
Hans Zischka (Helmholtz Center Munich, Munich, Germa-
ny) demonstrated his work on rat models for Wilson dis-
ease, a fatal liver disease. Due to a genetic defect in Wilson 
disease, copper ions accumulate in liver cells, leading to 
severe mitochondrial damage. Copper causes mitochondri-
al structural alterations, and physically impairs the mito-
chondrial membrane leading to mitochondrial membrane 
permeabilization and cell death. He demonstrated that 
treatment of rats with copper chelators reduced the det-
rimental copper load in mitochondria, rescues mitochon-
drial function and cell survival, preventing acute liver fail-
ure [23]. 
Alice Rossi (University of Padua, Padua, Italy) present-
ed her data describing the effects of Alzheimer’s disease-
causing mutations in the protease presenilin 2 affects mi-
tochondrial functionality. She showed that presenilin 2 
mutations impaired mitochondrial functionality, resulting 
in the depletion of cellular ATP levels. She is now elucidat-
ing how mutated presenilin 2 linked to familial Alzheimer’s 
disease induces mitochondrial impairments. 
 
CONCLUDING REMARKS 
The 2
nd
 International Symposium “One mitochondrion, 
many diseases. Biological and Molecular Perspectives.” in 
Freiburg (Germany) was the continuation of a previous 
symposium, which took place in Sherbrooke, Québec, Can-
ada in March 2015. In the first symposium, the role of mi-
tochondria was described in human patients, as well as in 
mammalian cell culture, yeast, and transgenic mouse mod-
els for different diseases, including mitochondrial disorders, 
inflammatory and neurodegenerative diseases, as well as 
cancer [24]. In the current symposium, the focus was more 
on basic mitochondrial research, including mitochondrial 
architecture, structure and integrity, or mitochondrial res-
piratory chain complexes. We plan our next symposium to 
take place in Montréal (Québec, Canada) in May 2017. We 
aim to bring mitochondrial researchers doing basic and 
clinical research together to discuss diverse human disor-
ders in different model systems. 
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